Assessment of haemoglobin a1c evolution using two statistical approaches (survival analysis and linear regression) in persons with diabetes mellitus

Biomedical Papers

Volumn 153, Issue 2, 2009, Pages 137-144

  Langova, Katerina ^a   Pribylova, Helena ^a   Kajabova, Marketa ^b   Luza, Jiri ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Survival analysis Linear regression Haemoglobin A1c Continuous glucose monitoring Diabetes mellitus

Indexed keywords

EID: 70149104806     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2009.023     Document Type: Article

References (29)

1. Bland M. An introduction to medical statistics. Oxford University Press 2000.
2. Deiss D, Bolinder J, Riveline JP, Battelino T, Bost E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diab Care 2006; 29 (12): 2730-2732.
3. Faber E, Koza V, Vitek A, Mayer J, Sedlacek P, Zak P, Zapletalova J, Benesova K, Krejcova H, Steinerova K, Maresova I, Cetkovsky P. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry. Neoplasma. 2007;54(5):443-6.
4. Gallo J, Langová K, Havránek V, Čechová I. Poor survival of ABG I hip prosthesis in younger patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008; 152(1):163-169.
5. Garg SK. Glucose Monitoring: An important tool for improving glucose control and reducing hypoglycemia. Diab Technol Therap 2008; 10 (1):1-4.
6. Hirsch IB, Amstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H. Clinical application of emerging sensor technologies in diabetes management: concensus guidelines for continuous glucose monitoring (CGM). Diab Technol Therap 2008;10(4): 232-246.
7. Chlup R, Jelenová D, Chlupová K, Zapletalová J, Chlupová L, Bartek J. Function and accuracy of glucose sensors beyond their stated expiry date. Diab Technol Therap 2006;8(4): 495-504.
8. Chlup R, Peterson K, Zapletalová J, Langová K, Kudlová P, Přibylová H, Matušková V. Relation between HbA1c and average one-month interstitial fluid glucose concentration (ISFG) determined by continuous glucose monitoring - preliminary results of an ongoing study. Diabetes 2007;56 (Suppl 1):A527 (Abstract 2083-PO).
9. Chlup R, Řehořová J, Langová K, Zapletalova J, Kudlova P, Přibylová H, Peterson K, Bartek J, Slezáková L. Effects of twomonth consumption of selected foods with low/high glycemic index and anthropometric parameters in healthy persons (DEGIF V). Diabetes 2007;56(Suppl1):A688(Abstract).
10. Chlup R, Zapletalová J, Sečkař P, Chlupová L, Táncosová S, Řezníčková M. Benefits of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 diabetes treated by means of an insulin pump. Biomed Papers 2004;148(1): 27-32.
11. Chlup R, Peterson K, Kudlova P, Hucikova J, Zapletalova J, Novotny D. Vliv konvenčního a kontinuálního selfmonitoringu glykemie na vývoj koncentrace HbA1c u osob s diabetem léčených inzulinovou pumpou. Diabetes a obezita. 2008 (16):55-64.
12. Chlupová K, Kohnert KD, Heinke P, Augstein P, Chlup R, Salzsieder E. Resultate kontinuerlicher Glukosemessungen (CGMS) unter ambulanten Bedingungen zur Beurteilung der Stoffwechseleinstellung bei T2DM. Diabetologie und Stoffwechsel 2006;1(1): 94(Abstract).
13. Jadviščoková T, Fajkusová Z, Pallayová M, Luža J, Kuzmina G. Occurence of adverse events due to continuous glucose monitoring. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep. 2007;151 (2): 263-266.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Statist Ass 1958; 53: 457-481.
15. Klein JP, Goel PK. Survival analysis: State of the Art. Kluwer Academic Publisher, Dordrecht, The Netherlands, 1992.
16. Köcher M, Černá M, Utíkal P, Kozák J, Šišola I, Bachleda P, Dráč P, Sekanina Z, Langová K.: Subintimální angioplastika ve femoropopliteální oblasti - střednědobé výsledky. Ces Radiol 2008; 62(2): 153-159.
17. Kudlová P, Chlup R. Selfmonitoring u osob s diabetem. Interní Med 2006;8(12): 539-544.
18. Langová K. Survival analysis for clinical studies. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008; 152(2):303-307.
19. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, et al. Selfmonitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006;49: 271-278.
20. Mazze RS, Strock E, Borgman S, Wesley D, Stout P, Racchini MS. Evaluating the accuracy, reliability and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time? Diabetes Technol Ther 2009:11(1):11-18.
21. Mlčák P, Fialová J, Trnková K, Chlup R. A continuous glucose monitoring system (CGMS) - A promising approach for improving metabolic control in person with type 1 diabetes mellitus treated by insulin pumps. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep 2004;148: 33-38.
22. Pazin-Filho A, Kottegen A, Bertoni AG, Russel S D, Selvin E, Rosamond WD, Coresh: HbA1c as a risk factor for heart failure in persons with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetologia 2008;51:2197-2204.
23. Peterson K, Chlup R, Langová K, Zapletalová J, Kudlová P, Přibylová H. Benefits of continuous glucose monitoring transmitted to Paradigm 722. Diabetes 2007; 56 (Suppl 1):A531 (Abstract 2099-PO).
24. Peterson K, Chlup R, Kudlova P, Slezakova L, Zapletalova J, Langova K, Doubravova B, Bartek J, Seckar P, Nakladalova M. Influence of oral antidiabetic drugs on hyperglycemic power of foods in persons with type II diabetes mellitus (DEGIF IV).Diabetes 2007; 56 (Suppl 1):A688 (Abstract).
25. Peterson K, Chlup R, Langová K, Zapletalová J, Kudlová P, Přibylová H. Benefits of Continuous Glucose Monitoring Transmitted to Paradign 722, Diabetes. 2007; 56(1): A531.
26. Peterson K, Zapletalova J, Kudlova P, Matuskova V, Bartek J, Novotny D, Chlup R. Benefits of 3-month continuous glucose monitoring for persons with diabetes using insulin pumps and sensors. Biomed Pap Med Fac Univ Palacký Olomouc Czech Rep. 2009;153 (1):47-52
27. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593-598.
28. Procházka V, Trněný M, Pytlik R, Vasová I, Král Z, Belada D, Kozák T, Kubáčková K, Siffnerová H, Matuška M, Lysý M, Bolomská I, Petráková K, Otavová B, Přibylová J, Švecová J, Papajik T, Hamouzová M, Petrová M, Zapletalová J, Langová K. Peripheral T-cell lymphoma, unspecified - the analysis of the data from the Czech Lymphoma Study Group (CLSG) registry. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007; 151(1):103-7.
29. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.